Validation of an immunohistochemical assay, CEACAM5 IHC 769, under development for use with the antibody-drug conjugate tusamitamab ravtansine (SAR408701)
LaPointe, Nichole, Hertle, Nick, Hsu, Shu Chi, Kellis, James, King, Nita, Littrell, Joshua, Nguyen, Quyen, Ren, Jianan, Srdanov, Marko Romeo, Tanna, Vaishali, Thakrar, Sanchit, Zhao, Tianxun, Saiz, Robert, Le Bail, Nathalie, Bauchet, Anne-Laure, Lacoste-Bourgeacq, Anne-Sophie, Chadjaa, Mustapha, Ferrari, Paul
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article